JOFOC 20250508_ - Final_Redacted.pdf

This document is a Justification and Approval (J&A) for Other than Full and Open Competition for maintenance and repair services for a Varian Medical Systems linear accelerator system at the National Cancer Institute (NCI). The acquisition is for a one-year base period with four one-year option periods, covering maintenance, repair, and support services for two Varian TrueBeam STX radiation therapy system platforms operated by the Radiation Oncology Branch (ROB) at the National Cancer Center Institute.

The system includes hardware components like two TrueBeam STX Radiation Therapy System Platforms, one Varian Respiratory Gating System, and three Visual Coaching Devices, along with software components including Varian Aria, Eclipse, and Insightive Software. Varian Medical Systems is identified as the sole source provider, maintaining proprietary rights to the system's parts, software, and configurations. The total estimated dollar value is not fully disclosed, but the contract will consolidate three existing contracts into one commercial purchase order. The NCI conducted market research through sources sought notices and pre-solicitation notices, receiving two responses that ultimately confirmed Varian as the most appropriate vendor.